Filter Results


Study status

(for at least one location)



Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-5 of 5 for Mayo Clinic Cancer Center — Research

  • Results filtered:
  • Study phase: 4 (3/4, 4, 4/5)
Edit search filters
  1. Patient Satisfaction in Mohs Micrographic Surgery with Supplemental Lidocaine Jelly

    Scottsdale/Phoenix, AZ

  2. A Study of Afatinib Treatment for Patients with Epidermal Growth Factor Receptor Mutation Positive Non-Small Cell Lung Cancer, Who Are Age 70 or Older

    Scottsdale/Phoenix, AZ

  3. Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma

    Rochester, MN

  4. A Study of Rociletinib (CO-1686) for Patients with a Mutant form of Non-Small Cell Lung Cancer.

    Scottsdale/Phoenix, AZ

  5. A Study to Evaluate an Adjunctive Anti-Seizure Medication to Treat Patients with Drug-Resistant Focal Epilepsy and High-Grade Glioma

    Jacksonville, FL


Mayo Clinic Footer